T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (942)	2/7/2002 12:56:55 AM
From: scaram(o)uche	of 2243

messages.yahoo.com messages.yahoo.com Let me get this straight..... Salomon Smith Barney sets a target of $55, 23 July 2001. Nothing material changes apart from the AN-1792 trial halt, but -- at $14 six months later -- they say "we heard nothing new today that makes us any more supportive/dismissive of the investment opportunity of ELN shares and we remain with a 2S (Neutral, Speculative Risk) rating." Give me a break. The SSB analysts are saying that they never even frigging read the deal details? EVERYONE ASSOCIATED WITH THE SECTOR KNEW EXACTLY WHAT ELAN WAS DOING. ANALYSTS CAN'T BE THIS BAD. THEY'RE JUST PLAIN COWARDLY.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next